ID   CMK-6
AC   CVCL_RM24
SY   CMK6
DR   cancercelllines; CVCL_RM24
DR   Wikidata; Q54813773
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=1991165;
CC   Population: Japanese.
CC   Sequence variation: Gene fusion; HGNC; 4024; FXR2 + HGNC; 11998; TP53; Name(s)=TP53-FXR2 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Asp49His (c.145G>C); ClinVar=VCV000135948; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2993; Down syndrome
DI   NCIt; C43223; Myeloid leukemia associated with Down syndrome
DI   ORDO; Orphanet_870; Down syndrome
DI   ORDO; Orphanet_99887; Acute megakaryoblastic leukemia in Down syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0216 ! CMK
SX   Male
AG   10M
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 05-10-23; Version: 12
//
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RA   Drexler H.G.;
RT   "The leukemia-lymphoma cell line factsbook.";
RL   (In) ISBN 9780122219702; pp.1-733; Academic Press; London (2001).
//
RX   PubMed=1991165; DOI=10.1182/blood.V77.3.481.481;
RA   Sakaguchi M., Sato T., Groopman J.E.;
RT   "Human immunodeficiency virus infection of megakaryocytic cells.";
RL   Blood 77:481-485(1991).
//